<SEC-DOCUMENT>0001178913-22-004019.txt : 20221114
<SEC-HEADER>0001178913-22-004019.hdr.sgml : 20221114
<ACCEPTANCE-DATETIME>20221114160608
ACCESSION NUMBER:		0001178913-22-004019
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20221114
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221114
DATE AS OF CHANGE:		20221114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		221385106

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cmmb="http://chemomab.com/20221114" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_c4648d413a80429490b83737684960a3" contextRef="c20221114to20221114" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_827b499388894d2983d2699b4fac3458" contextRef="c20221114to20221114">00-0000000</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_bb5eac91d82c47d694f161e9a8eda0ed" contextRef="c20221114to20221114">0001534248</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_7800ee96276548b596341b580ba682e4" contextRef="c20221114to20221114_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_6d5d9dde38ce41a79ef18960f5e679b6" contextRef="c20221114to20221114_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="cmmb-20221114.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20221114to20221114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-14</xbrli:startDate><xbrli:endDate>2022-11-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221114to20221114_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-14</xbrli:startDate><xbrli:endDate>2022-11-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221114to20221114_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-14</xbrli:startDate><xbrli:endDate>2022-11-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div> <div><br /></div>

      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b> UNITED STATES</b></p>
      <p style="font: 14pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>WASHINGTON, D.C. 20549</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;&#160;</p>
      <p style="font: 14pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_1e8d67a5e319479a96041d8c4f7e3915" contextRef="c20221114to20221114">8-K</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>CURRENT REPORT</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Pursuant to Section&#160;13 or 15(d)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>of the Securities Exchange Act of 1934</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_097c3bd6996d46e2bd4575c8433d9ffd" contextRef="c20221114to20221114" format="ixt:date-monthname-day-year-en">November 14, 2022</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 16pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_54f7699f403b4b8da0f3061dbb621ab8" contextRef="c20221114to20221114">Chemomab Therapeutics Ltd.</ix:nonNumeric><br />
        </b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>(Exact name of Registrant as Specified in Its Charter)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: top;">

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">State of <ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_ed7f83e55f0a4b08beddae26671ea988" contextRef="c20221114to20221114" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></td>

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_23f534d54203453daaea000a94b759db" contextRef="c20221114to20221114">001-38807</ix:nonNumeric><br />
            </td>

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_827b499388894d2983d2699b4fac3458">81-3676773</span><br />
            </td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(State or Other Jurisdiction</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(Commission</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(IRS Employer</b></td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>of Incorporation)</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>File Number)</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>Identification No.)</b></td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr>

    <td style="width: 50%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_e24b9d3f80794d4685c212a8f19bc425" contextRef="c20221114to20221114">Kiryat Atidim, Building 7</ix:nonNumeric></span><br />
            </td>

    <td style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_4fa2b9620e824a57b1f54dd90922a682" contextRef="c20221114to20221114">Tel Aviv</ix:nonNumeric>,
                <ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_b9d79dd8c8ac402da729318d023d8bec" contextRef="c20221114to20221114" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></b></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_7d3c117f227b4ad7b829a6bd78c06980" contextRef="c20221114to20221114">6158002</ix:nonNumeric><br />
              </b></td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b>(Address of principal executive offices)</b></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b>(Zip Code)</b></td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>Registrant&#8217;s telephone number, including area code: +<ix:nonNumeric name="dei:CityAreaCode" id="Fact_056db533a90749b29f8b400205334538" contextRef="c20221114to20221114">972</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_a465d30b3ba54a55af9eec32f997a7b4" contextRef="c20221114to20221114">77-331-0156</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>(Former name or former address, if changed since last report)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: top;">

    <td style="width: 5%; text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_58591e2e1f2443529562a6b7d3838234" contextRef="c20221114to20221114" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: 95%; text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_34813f63dc0844ef81c013044741f24c" contextRef="c20221114to20221114" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_c93b00f1407c48d2abcfa1faa8eb2967" contextRef="c20221114to20221114" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_ee53ffb1d4404dd9bf8384d2237b75eb" contextRef="c20221114to20221114" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: bottom;">

    <td style="width: 49%; text-align: center; white-space: nowrap; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Title of each class</b></td>

    <td style="width: 1%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 24%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Trading<br />
                Symbol(s)</b></td>

    <td style="width: 1%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 25%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Name of each <br />
                exchange<br />
                on&#160;which&#160;registered</b></td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_b123c56576e3485d98bde4754511ff63" contextRef="c20221114to20221114_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_efc8b1a62843452ea835025b22e31abb" contextRef="c20221114to20221114_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">CMMB</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;"><span style="-sec-ix-hidden:Fact_6d5d9dde38ce41a79ef18960f5e679b6">Nasdaq Capital Market</span><br />
            </td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;">&#160;</td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_adcba5d2ba7c41fa96ede1c9ee9b9160" contextRef="c20221114to20221114_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">Ordinary shares, no par value per share</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_e57ed6f5b2144c9b95a26c319b8d02b2" contextRef="c20221114to20221114_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">N/A</ix:nonNumeric></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;"><span style="-sec-ix-hidden:Fact_7800ee96276548b596341b580ba682e4">Nasdaq Capital Market</span>*</td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">* Not for trading; only in connection with the registration of American Depositary Shares.</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule&#160;12b-2 of the
        Securities Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter).</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Emerging growth company&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_dd30d57e27ef4063b7ff9d2b9c5d7da4" contextRef="c20221114to20221114" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
        accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160; <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_4060debb196f400b9b60e23eaa2c782f" contextRef="c20221114to20221114" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></p>
    </div>

    <div> <span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br />
      </span></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;"><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Item 5.02</span><span style="font-family: 'Times New Roman',Times,serif;">&#160;<span style="font-size: 10pt; font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
            Officers.</span></span></div>

      <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">(c) <span style="font-size: 10pt; font-style: italic;">Appointment of Chief Medical Officer &amp; VP, Drug
          Development</span></div>

      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
        <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On November 14, 2022, Chemomab Therapeutics Ltd. (the &#8220;Company&#8221;) announced the appointment of Dr. Matthew B.
          Frankel as Chief Medical Officer &amp; VP, Drug Development of the Company. Dr. Frankel&#8217;s appointment is effective as of November 14, 2022.</div>

      </div>

      <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The biographical information for Dr. Frankel appears below:</div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br />
      </div>

      <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">
        <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Dr. Matthew
            B. Frankel</span>, age 54, has 20 years of experience in the pharmaceutical industry, encompassing clinical development and medical affairs. From 2018 until November 2022, Dr. Frankel served as Vice President, Clinical Development and Medical
          Affairs, Specialty Pharma at Boehringer-Ingelheim Pharmaceuticals, Inc. Prior to that, he served as the Vice President &amp; Head, Immunology and Dermatology Medical Unit at Novartis Pharmaceuticals Corporation from 2016 to 2018. From 2012 to
          2016, Dr. Frankel served as the Executive Medical Director of Sandoz and from 2010 through 2012 held the role of Global Medical Director, Clinical Development at Reata Pharmaceuticals (RETA). From 2003 through 2010, he held various senior roles
          across different companies in the research field. Dr. Frankel received his undergraduate degree from Vassar College, his MD from the University of California, Los Angeles School of Medicine, and his MBA from the J. L. Kellogg Graduate School of
          Management.</div>

      </div>

      <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Other than that which is disclosed herein, there are no arrangements or understandings
        between Dr. Frankel and any other persons pursuant to which he was appointed to serve as Chief Medical Officer &amp; VP, Drug Development and there are no family relationships between Dr. Frankel and any director or executive officer of the
        Company. Dr. Frankel has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.</div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br />
      </div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;"><span style="text-decoration: underline;">Employment Agreement and Other Compensatory Arrangements</span></div>

        <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;"><span style="text-decoration: underline;"> <br />
          </span></div>

      </div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">
          <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In November 2022, Chemomab Therapeutics Inc., the Company's wholly owned subsidiary, entered into an Executive
            Employment Agreement with Dr. Frankel (the &#8220;Agreement&#8221;), which took effect on November 14, 2022. Dr. Frankel will receive an annual base salary of $450,000, and will be part of the Company&#8217;s bonus program with a yearly bonus potential of 45% of
            his base annual base salary, which bonus will be based on the board of directors&#8217; assessment of Dr. Frankel&#8217;s individual performance and the overall performance of the Company. Dr. Frankel will also be eligible to receive a special signing
            bonus of $200,000, whereby $100,000 will be payable within sixty (60) days of Dr. Frankel&#8217;s start date and $100,000 will be payable within one hundred and twenty (120) days of his start date. Additionally, Dr. Frankel will receive options to
            purchase 125,000 American Depositary Receipts (each representing twenty (20) ordinary shares of the Company), which options will vest over a four year period with 25% vesting on the first anniversary of the grant date of these options and the
            remainder vesting in equal amounts over the ensuing 36 month period.</div>

        </div>

      </div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;"><br />
        </div>

      </div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">The foregoing description of the terms of the Agreement does not purport to be a complete description and is qualified in its entirety by
          reference to the Agreement, which is attached hereto as Exhibit 10.1 and is incorporated by reference in its entirety into this Item 5.02.</div>

      </div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br />
      </div>

      <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Item 7.01 Regulation FD Disclosure.</div>

      <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; text-indent: 27pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
        <div style="text-align: justify; text-indent: 27pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As described in Item 5.02 above, on November 14, 2022, the Company issued a press release announcing the
          appointment of Dr. Matthew B. Frankel as the Chief Medical Officer &amp; VP, Drug Development of the Company, which appointment is effective immediately. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by
          reference.</div>

      </div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br />
      </div>

      <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Item 9.01 Financial Statements and Exhibits.</div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br />
      </div>

      <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: italic;">(d) Exhibits</div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 11%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Exhibit Number</div>
            </td>

    <td style="width: 89%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Exhibit Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 11%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 238); font-size: 10pt;"><a href="exhibit_99-1.htm"><span style="text-decoration: underline;">99.1</span></a></div>
            </td>

    <td style="width: 89%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 238); font-size: 10pt;"><a href="exhibit_99-1.htm">Press release issued by Chemomab
                  Therapeutics Ltd. dated November 14, 2022</a></div>
            </td>

  </tr>


</table>
      <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter"></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader"></div>

      </div>

      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br />
      </div>

      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">&#160;</div>

      <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
        signed on its behalf by the undersigned hereunto duly authorized.</div>

      <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.17%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</div>
            </td>

    <td colspan="2" style="width: 37.05%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
            </td>

    <td style="width: 13.78%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.17%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.48%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 33.56%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 13.78%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.17%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">Date: November 14, 2022</div>
            </td>

    <td style="width: 3.48%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">By:</div>
            </td>

    <td style="width: 33.56%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">/s/ Donald Marvin</div>
            </td>

    <td style="width: 13.78%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.17%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.48%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 33.56%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Name: Donald Marvin</div>
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Title: Executive V.P., Chief Financial Officer and</div>
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Chief Operating Officer</div>
            </td>

    <td style="width: 13.78%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-size: 10pt;">&#160;</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>

      <div><span style="font-family: 'Times New Roman',Times,serif;"> </span></div>
</div>

    <div><span style="font-family: 'Times New Roman',Times,serif;"> </span></div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

  </div>

  <div><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
  </font>
  <div>
    <div class="BRPFPageHeader">
      <div style="text-align: right;"><u><font style="font-weight: bold;"> </font></u>
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u><br>
      </div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z68ec1e31987247a98124a56b12c0d40c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><img width="259" height="73" src="image0.jpg"></div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Chemomab Announces Appointment of Matthew Frankel, MD, MBA </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">as Chief Medical Officer</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: Arial,sans-serif; font-size: 10pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">TEL AVIV, Israel, November 14, 2022 </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">-- Chemomab Therapeutics, Ltd. (<font style="color: rgb(41, 56, 72);">Nasdaq: CMMB) (Chemomab), </font><font style="color: rgb(0, 0, 0);">a clinical-stage biotechnology
          company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced the appointment of Matthew Frankel, MD, MBA as Chief Medical Officer (CMO) and Vice President
          of Drug Development.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#8220;We believe Dr. Frankel&#8217;s wealth of experience across all aspects of clinical development and medical affairs, along with his
      outstanding performance in helping to bring biologic and small molecule drugs to market for both rare and chronic diseases, will be invaluable as we advance the CM-101 clinical program,&#8221; said Dale Pfost, PhD, Chief Executive Officer of Chemomab. &#8220;We
      have greatly benefitted from the singular talents of interim CMO Dave Weiner, who will be staying on as a Senior Advisor, and are fortunate now to have Matt Frankel, with his exceptional breadth of experience and track record of success, joining as
      our full- time CMO.&#8221;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Dr. Frankel most recently served as Vice President, Clinical Development and Medical Affairs, Specialty Pharma at Boehringer
      Ingelheim, where he led functional teams developing new drugs for oncology, immunology, pulmonary, and central nervous system diseases. Previously Dr. Frankel was Vice President &amp; Head, Immunology and Dermatology Medical Unit at Novartis, where
      he oversaw medical affairs activities and late phase clinical development for Cosentyx<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Ilaris<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, and Zortress<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>. At the Sandoz unit of Novartis, Dr. Frankel successfully built and led the medical affairs organization
      supporting the biopharmaceutical, biosimilar and generics businesses for launches including Kerydin<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Glatopa<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and Zarxio<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#8220;Chemomab&#8217;s CM-101 is an intriguing investigational drug, with its novel CCL24 target, dual mechanism of action, breadth of
      application and disease-modifying potential in serious progressive diseases with few effective treatment options,&#8221; said Dr. Frankel. &#8220;Chemomab scientists have assembled an impressive body of preclinical and early clinical evidence supporting the
      utility of their approach, and I welcome the opportunity to join this talented team as we move to rapidly expand and accelerate our CM-101 clinical programs.&#8221;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Earlier in his career, Dr. Frankel held clinical development leadership roles across geographies and therapeutic disease areas at
      Reata, Fibrogen, Abbott Labs, and Schering Plough. Dr. Frankel received a BA degree from Vassar College, an MD degree from the University of California School of Medicine, Los Angeles and an MBA from the J. L. Kellogg Graduate School of Management at
      Northwestern University.</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">He is board certified in internal medicine.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">About Chemomab Therapeutics Ltd.</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Chemomab is a clinical stage biotechnology company focusing on the discovery and development of innovative therapeutics for
      fibrotic and inflammatory diseases with high unmet need. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody designed to bind and block CCL24
      activity. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is currently in Phase 2 trials for primary sclerosing cholangitis and liver fibrosis, with a Phase 2 trial in
      systemic sclerosis expected to open around year-end, with first patients enrolled in early 2023. For more information on Chemomab, visit <font style="color: rgb(0, 0, 255);"><u>chemomab.com</u></font><font style="color: rgb(0, 0, 0);">.</font></div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><font style="color: rgb(0, 0, 0);"> <br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Forward Looking Statements</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These
      forward-looking statements include, among other things, statements regarding the clinical development pathway for CM-101; the future operations of Chemomab and its ability to successfully initiate and complete clinical trials and achieve regulatory
      milestones; the nature, strategy and focus of Chemomab; the development and commercial potential and potential benefits of any product candidates of Chemomab; and that the product candidates have the potential to address high unmet needs of patients
      with serious fibrosis-related diseases and conditions. Any statements contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based upon
      Chemomab&#8217;s current expectations. Forward-looking statements involve risks and uncertainties. Because such statements deal with future events and are based on Chemomab&#8217;s current expectations, they are subject to various risks and uncertainties and
      actual results, performance or achievements of Chemomab could differ materially from those described in or implied by the statements in this presentation, including: the uncertain and time-consuming regulatory approval process; risks related to
      Chemomab&#8217;s ability to correctly manage its operating expenses and its expenses; Chemomab&#8217;s plans to develop and commercialize its product candidates, focusing on CM-101; the timing of initiation of Chemomab&#8217;s planned clinical trials; the timing of
      the availability of data from Chemomab&#8217;s clinical trials; the timing of any planned investigational new drug application or new drug application; Chemomab&#8217;s plans to research, develop and commercialize its current and future product candidates; the
      clinical utility, potential benefits and market acceptance of Chemomab&#8217;s product candidates; Chemomab&#8217;s commercialization, marketing and manufacturing capabilities and strategy; Chemomab&#8217;s ability to protect its intellectual property position; and
      the requirement for additional capital to continue to advance these product candidates, which may not be available on favorable terms or at all. Additional risks and uncertainties relating to Chemomab&#8217;s and its business can be found under the caption
      &#8220;Risk Factors&#8221; and elsewhere in Chemomab&#8217;s filings and reports with the SEC. Chemomab expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any
      change in Chemomab&#8217;s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.</div>
    <div style="text-align: left; margin-right: 6.4pt; margin-left: 5.75pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Contacts:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z86b5b6ef6d1d42d1a22dff791b0aad2b">

          <tr>
            <td style="width: 50%;">
              <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Media:</font></div>
              <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Barbara Lindheim&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
              <div>
                <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Chemomab Therapeutics&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
                <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Consulting Vice President&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
                <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Investor &amp; Public Relations,&#160;&#160;</font></div>
                <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><font style="font-size: 10pt; color: rgb(0, 0, 0);">Strategic Communications</font></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Phone: +1-917-355-9234</div>
                <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 255); font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>barbara@chemomab.com</u></div>
                <font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </font></div>
            </td>
            <td style="width: 50%; text-align: left; vertical-align: top;">
              <div><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><font style="font-weight: bold;">Investor Relations:</font></font></div>
              <div><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Irina Koffler</font></div>
              <div><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">LifeSci Advisors, LLC</font></div>
              <div>
                <div><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Phone: +1-917-734-7387</font></div>
                <div><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><font style="font-size: 10pt; color: rgb(0, 0, 255);"><u>ir@chemomab.com</u>&#160;</font> </font></div>
                <font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </font></div>

            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
  <font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cmmb-20221114.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<xs:schema targetNamespace="http://chemomab.com/20221114" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:cmmb="http://chemomab.com/20221114" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20221114_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20221114_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20221114_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://chemomab.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" id="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OrdinarySharesNoParValuePerShareMember" id="cmmb_OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cmmb-20221114_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://chemomab.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20221114.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://chemomab.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="definition: EntityListingsLineItems to EntityExTransitionPeriod" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20221114.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20221114.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesNoParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to OrdinarySharesNoParValuePerShareMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cmmb-20221114_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" id="dei_EntityExTransitionPeriod_lbl">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable_lbl" xml:lang="en-US" id="dei_EntityListingsTable_lbl">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:title="label: EntityListingsTable to dei_EntityListingsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems_lbl" xml:lang="en-US" id="dei_EntityListingsLineItems_lbl">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20221114.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xml:lang="en-US" id="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:to="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xlink:title="label: AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember to cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20221114.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xml:lang="en-US" id="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1">Ordinary shares, no par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrdinarySharesNoParValuePerShareMember" xlink:to="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xlink:title="label: OrdinarySharesNoParValuePerShareMember to cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cmmb-20221114_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.1.5080 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://chemomab.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20221114.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://chemomab.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20221114.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20221114.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesNoParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to OrdinarySharesNoParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: EntityListingsLineItems to EntityExTransitionPeriod" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "9 AT# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"#_LJN?YM^E>QUMBYN53EZ(BC&T;]PHHHKE-0J&Z_P"/.?\ ZYM_*IJANO\
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MRK?Q)>K+A\*/"_VAO]=X?_W9_P#V2NZ^#W_),=+^LO\ Z,:N%_:&_P!;X?\
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M7^&- UB'5;"VG2ZA)*,TQ8#((/'T-=E3Q-6-22<14H.*LPKY1UW_ )+)<_\
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M>\1^"/#_ (J7.JZ>DDP&%G0E)!_P(=?QJJ5=*/)45T*=-M\T=SF+;XW^#IH
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M1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV/;(-;=<;33LS9.ZN%%%%(84444 %%%% !1110 4444 %%%% !1110 4444
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M8^I(I6TN,M45S6IQ:G;7UHD>KRA+JX*;?+7Y!@GBMZTAE@MECFN&N)!G,C
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1_>LMO^0\/\]JUZ<GH@1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139687042310400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 14, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 14,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Chemomab Therapeutics Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Kiryat Atidim, Building 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6158002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">77-331-0156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember', window );">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CMMB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember', window );">Ordinary shares, no par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>form8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cmmb="http://chemomab.com/20221114"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cmmb-20221114.xsd" xlink:type="simple"/>
    <context id="c20221114to20221114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2022-11-14</startDate>
            <endDate>2022-11-14</endDate>
        </period>
    </context>
    <context id="c20221114to20221114_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-14</startDate>
            <endDate>2022-11-14</endDate>
        </period>
    </context>
    <context id="c20221114to20221114_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-14</startDate>
            <endDate>2022-11-14</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20221114to20221114"
      id="Fact_c4648d413a80429490b83737684960a3">false</dei:AmendmentFlag>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20221114to20221114"
      id="Fact_827b499388894d2983d2699b4fac3458">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityCentralIndexKey
      contextRef="c20221114to20221114"
      id="Fact_bb5eac91d82c47d694f161e9a8eda0ed">0001534248</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20221114to20221114_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_7800ee96276548b596341b580ba682e4">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20221114to20221114_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_6d5d9dde38ce41a79ef18960f5e679b6">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20221114to20221114"
      id="Fact_1e8d67a5e319479a96041d8c4f7e3915">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20221114to20221114"
      id="Fact_097c3bd6996d46e2bd4575c8433d9ffd">2022-11-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20221114to20221114"
      id="Fact_54f7699f403b4b8da0f3061dbb621ab8">Chemomab Therapeutics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20221114to20221114"
      id="Fact_ed7f83e55f0a4b08beddae26671ea988">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20221114to20221114"
      id="Fact_23f534d54203453daaea000a94b759db">001-38807</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20221114to20221114"
      id="Fact_e24b9d3f80794d4685c212a8f19bc425">Kiryat Atidim, Building 7</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20221114to20221114"
      id="Fact_4fa2b9620e824a57b1f54dd90922a682">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20221114to20221114"
      id="Fact_b9d79dd8c8ac402da729318d023d8bec">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="c20221114to20221114"
      id="Fact_7d3c117f227b4ad7b829a6bd78c06980">6158002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20221114to20221114"
      id="Fact_056db533a90749b29f8b400205334538">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20221114to20221114"
      id="Fact_a465d30b3ba54a55af9eec32f997a7b4">77-331-0156</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20221114to20221114"
      id="Fact_58591e2e1f2443529562a6b7d3838234">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20221114to20221114"
      id="Fact_34813f63dc0844ef81c013044741f24c">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20221114to20221114"
      id="Fact_c93b00f1407c48d2abcfa1faa8eb2967">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20221114to20221114"
      id="Fact_ee53ffb1d4404dd9bf8384d2237b75eb">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20221114to20221114_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_b123c56576e3485d98bde4754511ff63">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20221114to20221114_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_efc8b1a62843452ea835025b22e31abb">CMMB</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="c20221114to20221114_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_adcba5d2ba7c41fa96ede1c9ee9b9160">Ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20221114to20221114_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_e57ed6f5b2144c9b95a26c319b8d02b2">N/A</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20221114to20221114"
      id="Fact_dd30d57e27ef4063b7ff9d2b9c5d7da4">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20221114to20221114"
      id="Fact_4060debb196f400b9b60e23eaa2c782f">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MH[#-,@W@][40^N7$O)\L7R^/_@%02P,$%     @ P(!N59^@&_"Q @  X@P
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ P(!N50=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" # @&Y5=3T!0>X    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " # @&Y5F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ," ;E6"
M(C_C  4  &H6   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " # @&Y5GZ ;\+$"  #B#   #0
M    @ %##0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ," ;E67BKL<P
M !,"   +              "  1\0  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M ," ;E4<.&7J/P$  #P"   /              "  0@1  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " # @&Y5)!Z;HJT   #X 0  &@
M@ %T$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #
M@&Y599!YDAD!  #/ P  $P              @ %9$P  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"  "C%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://chemomab.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName -  form8k.htm 11</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="form8k.htm">form8k.htm</File>
    <File>cmmb-20221114.xsd</File>
    <File>cmmb-20221114_def.xml</File>
    <File>cmmb-20221114_lab.xml</File>
    <File>cmmb-20221114_pre.xml</File>
    <File>exhibit_99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "cmmb-20221114_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cmmb-20221114_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmmb-20221114_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cmmb-20221114.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 36,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "cmmb",
   "nsuri": "http://chemomab.com/20221114",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8k.htm",
      "contextRef": "c20221114to20221114",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://chemomab.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8k.htm",
      "contextRef": "c20221114to20221114",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]"
       }
      }
     },
     "localname": "AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://chemomab.com/20221114",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, no par value per share [Member]"
       }
      }
     },
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://chemomab.com/20221114",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001178913-22-004019-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-22-004019-xbrl.zip
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ME=?UEKWB_^]>T13F_T_=]'=02P,$%     @ P(!N5>RW45TX!P  GU   !4
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MD]LLHZRXOUY%U&::@#%ZM<Z 42N?#VD<HAG'&M72NLJ CN,$0UFR7CK)AZF
M;BR&85\#3U>,]H^.^RW *]VW!73GQZK1XFW8"FI'8/9AR]B:XX+9;6OVV^+"
M4I.U_^7P^/2X_Y%<?CD\[Y\=_GIYM']!OET>M!\)1'6SW77?%H/N)29/X.^L
MTJ11Q%C,WSZ+;OE :]M:)AM_@(Z;;=OY0_9\E3WX47J^07OP&D(@R_ES (YU
M;YECO0GK\%K9L'1>_3CM;<A42#:L=Z'H:^36UEXGZY #W-3"\":3JVB]^.)/
MR[(!R_*C@+%[VY(_0,=O,1\;[<J#_6F\^;AWMV5X'<3*2^-ZM:,[O[7/VCO%
MROULU;9<NZ<)>[U]442?CCDN3R2#DNB?#N"M/?^!%@4><8G$_);Y)?>R/%WE
MM4HK\N?O-BF_E3"'D*P*(?DQ#;Y7Z6K-8SZQ&@NMOB@0RK^EBP)ETK)P=+&6
M@D/=PYAF6KT2JA7Y;GX)H?'\&#8ND81%ONYV_)1-Y?@-\U$,#_\/4$L! A0#
M%     @ P(!N54V_9:'G P  1Q(  !$              ( !     &-M;6(M
M,C R,C$Q,30N>'-D4$L! A0#%     @ P(!N57V\%.(N!P  VT<  !4
M         ( !%@0  &-M;6(M,C R,C$Q,31?9&5F+GAM;%!+ 0(4 Q0    (
M ," ;E6(9:KMC0H  /-O   5              "  7<+  !C;6UB+3(P,C(Q
M,3$T7VQA8BYX;6Q02P$"% ,4    " # @&Y5[+=173@'  "?4   %0
M        @ $W%@  8VUM8BTR,#(R,3$Q-%]P<F4N>&UL4$L! A0#%     @
MP(!N587*"<L<$   Z$   !               ( !HAT  &5X:&EB:71?.3DM
M,2YH=&U02P$"% ,4    " # @&Y5><LC!?@9  !"I   "@
F@ 'L+0  9F]R;3AK+FAT;5!+!08     !@ & 'X!   ,2      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
